PT88248A - Processo para a preparacao de composicoes farmaceuticas contendo rnas de cadeia dupla com actividade topica - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo rnas de cadeia dupla com actividade topica

Info

Publication number
PT88248A
PT88248A PT88248A PT8824888A PT88248A PT 88248 A PT88248 A PT 88248A PT 88248 A PT88248 A PT 88248A PT 8824888 A PT8824888 A PT 8824888A PT 88248 A PT88248 A PT 88248A
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
ribs
preparation
compositions containing
double chain
Prior art date
Application number
PT88248A
Other languages
English (en)
Other versions
PT88248B (pt
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of PT88248A publication Critical patent/PT88248A/pt
Publication of PT88248B publication Critical patent/PT88248B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Details Or Accessories Of Spraying Plant Or Apparatus (AREA)
  • Credit Cards Or The Like (AREA)
  • Holo Graphy (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
PT88248A 1987-08-12 1988-08-11 Processo para a preparacao de composicoes farmaceuticas contendo rnas de cadeia dupla com actividade topica PT88248B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8422687A 1987-08-12 1987-08-12

Publications (2)

Publication Number Publication Date
PT88248A true PT88248A (pt) 1989-06-30
PT88248B PT88248B (pt) 1995-03-01

Family

ID=22183613

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88248A PT88248B (pt) 1987-08-12 1988-08-11 Processo para a preparacao de composicoes farmaceuticas contendo rnas de cadeia dupla com actividade topica

Country Status (20)

Country Link
EP (1) EP0303516B1 (pt)
JP (1) JP2714021B2 (pt)
KR (1) KR970007904B1 (pt)
CN (1) CN1031325A (pt)
AT (1) ATE108066T1 (pt)
AU (3) AU2053688A (pt)
CA (1) CA1327001C (pt)
DE (1) DE3850535T2 (pt)
DK (1) DK449988A (pt)
FI (1) FI883734A (pt)
HU (1) HU209749B (pt)
IE (1) IE66830B1 (pt)
IL (1) IL87415A (pt)
MX (1) MX12643A (pt)
NO (1) NO883564L (pt)
NZ (1) NZ225755A (pt)
PH (1) PH31174A (pt)
PT (1) PT88248B (pt)
RU (1) RU2061470C1 (pt)
ZA (1) ZA885874B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
JPH04507083A (ja) * 1989-05-19 1992-12-10 ヘム・リサーチ・インコーポレーテッド 規定された構造の短い治療用ｄｓＲＮＡ
AU6714094A (en) * 1993-04-28 1994-11-21 Ribozyme Pharmaceuticals, Inc. Ocular delivery of nucleic acid
JP2690276B2 (ja) * 1995-01-10 1997-12-10 科学技術振興事業団 静電結合型高分子ミセル薬物担体とその薬剤
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
JP4187413B2 (ja) 1998-03-20 2008-11-26 コモンウェルス サイエンティフィック アンドインダストリアル リサーチ オーガナイゼーション 遺伝子発現の制御
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
WO2000044914A1 (en) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
DK1309726T4 (en) 2000-03-30 2019-01-28 Whitehead Inst Biomedical Res RNA Sequence-Specific Mediators of RNA Interference
CZ308053B6 (cs) 2000-12-01 2019-11-27 Max Planck Gesellschaft Izolovaná molekula dvouřetězcové RNA, způsob její výroby a její použití
EP1229134A3 (en) 2001-01-31 2004-01-28 Nucleonics, Inc Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
JP2005324511A (ja) * 2004-05-17 2005-11-24 Kawamura Sangyo Kk 積層体及びその製造方法
UA93354C2 (ru) * 2004-07-09 2011-02-10 Гилиад Сайенсиз, Инк. Местный противовирусный препарат
EP2351577A1 (en) * 2004-12-29 2011-08-03 Mannkind Corporation Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
FR2885808B1 (fr) * 2005-05-19 2007-07-06 Oreal Vectorisation de dsrna par des particules cationiques et utilisation topique.
US9139850B2 (en) 2005-05-19 2015-09-22 L'oreal Vectorization of dsRNA by cationic particles and topical use
KR20080106219A (ko) * 2006-03-06 2008-12-04 나노캬리아 가부시키가이샤 소수성 화합물의 안정화제
WO2010114169A1 (en) * 2009-03-31 2010-10-07 Japan As Represented By The Director-General Of National Institute Of Infectious Diseases Method for prophylaxis of influenza using vaccine for intranasal administration
CN105434341B (zh) * 2015-12-22 2018-07-10 肇庆大华农生物药品有限公司 一种兽用聚腺尿苷酸注射液及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3582468A (en) * 1968-09-27 1971-06-01 Merck & Co Inc Recovery of double-stranded ribonucleic acid
BE793157A (fr) * 1971-12-21 1973-06-21 Beecham Group Ltd Substance antivirale
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
US4415548A (en) * 1980-02-12 1983-11-15 Schmid Laboratories, Inc. Spermicidally lubricated prophylactics and method for making same
JPS57209050A (en) * 1981-06-19 1982-12-22 Jekusu Kk Condome
US4507281A (en) * 1981-10-13 1985-03-26 Exovir, Inc. Interferon-containing compositions
JPS59124514U (ja) * 1983-02-10 1984-08-22 不二ラテックス株式会社 避妊効果を確実に向上させたコンド−ム
FR2556727B1 (fr) * 1983-12-19 1990-01-19 Biostabilex Labo Pharma Nouvelles compositions therapeutiques a base d'adn a haut poids moleculaire et leur procede de preparation
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
IL87415A (en) 1993-05-13
HUT47855A (en) 1989-04-28
AU1736592A (en) 1992-07-30
FI883734A0 (fi) 1988-08-11
FI883734A (fi) 1989-02-13
AU1001395A (en) 1995-03-09
PT88248B (pt) 1995-03-01
DE3850535T2 (de) 1995-01-12
JP2714021B2 (ja) 1998-02-16
IE66830B1 (en) 1996-02-07
KR890003387A (ko) 1989-04-14
DK449988D0 (da) 1988-08-11
ATE108066T1 (de) 1994-07-15
EP0303516A2 (en) 1989-02-15
JPH01139531A (ja) 1989-06-01
MX12643A (es) 1993-09-01
NZ225755A (en) 1990-03-27
EP0303516A3 (en) 1989-12-06
IL87415A0 (en) 1989-01-31
HU209749B (en) 1994-10-28
NO883564D0 (no) 1988-08-11
EP0303516B1 (en) 1994-07-06
RU2061470C1 (ru) 1996-06-10
CN1031325A (zh) 1989-03-01
AU2053688A (en) 1989-04-20
NO883564L (no) 1989-02-13
CA1327001C (en) 1994-02-15
KR970007904B1 (ko) 1997-05-17
DE3850535D1 (de) 1994-08-11
ZA885874B (en) 1989-04-26
IE882398L (en) 1989-02-12
PH31174A (en) 1998-03-20
DK449988A (da) 1989-02-13

Similar Documents

Publication Publication Date Title
PT88248A (pt) Processo para a preparacao de composicoes farmaceuticas contendo rnas de cadeia dupla com actividade topica
MY138860A (en) Hiv protease inhibitors.
ATE231839T1 (de) Polyaromatische antivirale zusammensetzungen
ES2165269A1 (es) Derivados de alfa-cetoamidas.
DK46787D0 (da) Antiviralt middel
GR3035014T3 (en) N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors
ATE376445T1 (de) Synergistische hemmung von viralreplikation durch langkettigen kohlenwasserstoffe und nucleosid- analoge
ATE74276T1 (de) Antivirale kombinationen und zusammensetzungen dafuer.
AR009935A1 (es) Un compuesto efectivo para inhibir aspartilproteasa, composiciones que lo incorporan y metodos para prevenir o tratar infecciones con hiv
DE69838980D1 (de) Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen
BR9708720A (pt) Composição farmacêutica e processo para o tratamento de demência por hiv.
ES2010559A6 (es) Procedimiento de preparacion de composiciones farmaceuticas antivirales de aplicacion externa que se acumulan en la piel.
AU2396900A (en) Treatment and prevention of hiv and other viral infections
MY117535A (en) Hiv protease inhibitors

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940804

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19970228